(June 11 20:32) Reuters.com Business
Takeda Pharmaceutical Co Ltd has agreed to sell a portfolio of over-the-counter and prescription drugs marketed in the Asia Pacific region to South Korea's Celltrion Inc for $278 million, it said on Thursday
You can find the original article
here